UK’s CMA Issues Fines Over Fludrocortisone

Amilco, Aspen And Tiofarma Named In UK Investigation

The UK’s CMA has issued fines of nearly £2.3m after formally concluding that three firms participated in illegal arrangements over fludrocortisone that violated competition law.

CMA
The CMA has completed its fludrocortisone probe • Source: Shutterstock

More from Regulation

More from Policy & Regulation